Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asta Co's EBIT per Share for the
three
months ended in Jun. 2026 was ₩32.60.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₩-147.01.
During the past 3 years, the average EBIT per Share Growth Rate was 5.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -2.60% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 10.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Asta Co's EBIT per Share or its related term are showing as below:
XKRX:246720'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -11.4 Med: 0.8 Max: 34.3
Current: 5.8
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Asta Co was 34.30% per year. The lowest was -11.40% per year. And the median was 0.80% per year.
XKRX:246720's 3-Year EBIT Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 9.4
vs XKRX:246720: 5.80
Asta Co's EBIT for the
three
months ended in Jun. 2026 was ₩534 Mil.
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Asta Co EBIT per Share Related Terms
Asta Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Asta Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-147.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asta Co (XKRX:246720) has a EBIT per Share of ₩-147.01 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Asta Co and its competitors.
Is Asta Co's EBIT per Share too high?
Asta Co's current EBIT per Share is ₩-147.01. Overall, Asta Co has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Asta Co's EBIT per Share compare to ISRG and BDX?
Asta Co's EBIT per Share of ₩-147.01 can be compared against companies in the Medical Devices & Instruments industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Asta Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asta Co's current EBIT per Share is ₩-147.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asta Co stock overvalued right now?
Asta Co (XKRX:246720) has a current EBIT per Share of ₩-147.01. The stock's GF Value™ is ₩4,746.50, compared to a current price of ₩6,070.00 — trading 27.9% above its estimated fair value. The current EBIT per Share is ₩-147.01. Asta Co's overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Asta Co (XKRX:246720), the current EBIT per Share is ₩-147.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asta Co (XKRX:246720) Overvalued in 2026?
Based on GuruFocus' analysis, Asta Co stock appears to be overvalued.
The current stock price of ₩6,070.00 is trading 27.9% above its estimated GF Value™ of ₩4,746.50.
Key valuation signals for XKRX:246720:
EBIT per Share: ₩-147.01
GF Value™: ₩4,746.50 vs. price of ₩6,070.00 (27.9% above fair value)
No single metric tells the full story. See the XKRX:246720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asta Co Ltd is a technology-based company that has been developing, manufacturing, and selling MALDI-TOF-based mass spectrometry instruments and related consumables. Its products are Microbial Identification, Microwave Digestion System, Surface/Organic/Inorganic analysis, Gas analysis, and Others.
71GF Score
Get the complete analysis for XKRX:246720
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:246720 has been successfully added to your 
